Codexis is a leader in the development of innovative bio-based solutions for pharmaceutical chemical process development and manufacturing. The company’s unique protein and strain engineering technology platform creates superior biological catalysts - either enzymes or fermentation strains - crafted specifically for cutting-edge chemical processes that can enable pharmaceutical process development, shorten process development timelines, and dramatically improve existing manufacturing processes. Codexis has successfully applied our proprietary recombination technology to create novel biocatalysts used in the synthesis of small molecule therapeutics with exquisite enantioselectivity and manufacturing efficiency. The technology has been proven on commercial scale on some of the highest profile "blockbuster" intermediates on the market today. As the manufacturing division of Codexis, Codexis Pharma Services focuses on the screening, development and application of novel enzymes for efficient pharmaceutical production. Codexis can deliver the flexibility and competitive solutions your company needs to compete.